Clinical Trial Update: An-Art Study: Atrioventricular (AV) Node Ablation in Cardiac Resynchronisation Therapy [EARLY_Phase 1]

View source ↗

Summary

An early-phase clinical trial evaluating AV node ablation in cardiac resynchronisation therapy for Congestive Heart Failure was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Snippet

Sponsor: University Hospital, Basel, Switzerland | Conditions: Congestive Heart Failure | EARLY_Phase 1 | Status: WITHDRAWN